Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Change in Account Payables (2010 - 2020)

Grifols' (GRFS) quarterly Change in Account Payables came in at -$25.7 million in Q1 2020, up 53.91% YoY from -$16.7 million in Q2 2019, and up 67.14% on a QoQ basis from -$78.2 million in Q4 2019.

Grifols (GRFS) Change in Account Payables (2010 - 2020) Analysis & Trends

Grifols (GRFS) has 11 years of Change in Account Payables data on file, last reported at -$25.7 million in Q1 2020.

  • Quarterly Change in Account Payables rose 53.91% year-over-year to -$25.7 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was -$155.5 million (down 134.7% YoY) and the FY2025 annual result came in at $109.4 million, up 253.09% from the prior year.
  • Change in Account Payables climbed to -$25.7 million in Q1 2020, from -$78.2 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $81.5 million in Q4 2016 to a low of -$78.2 million in Q4 2019.
  • A 5-year average of -$5.2 million and a median of $4.2 million in 2018 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2016 — Change in Account Payables jumped 128.83% — and 2019, when it plunged 1957.3%.
  • Tracing GRFS's Change in Account Payables over 5 years: stood at $81.5 million in 2016, then slumped by 40.67% to $48.3 million in 2017, then tumbled by 91.29% to $4.2 million in 2018, then sank by 1957.3% to -$78.2 million in 2019, then jumped by 67.14% to -$25.7 million in 2020.
  • The last three Change in Account Payables figures came in at -$25.7 million (Q1 2020), -$78.2 million (Q4 2019), and -$55.8 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 18.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -25.70 Mn
Mar 31, 2020 -25.70 Mn
Dec 31, 2019 -78.22 Mn
Dec 31, 2019 -78.22 Mn
Mar 31, 2019 -55.77 Mn
Mar 31, 2019 -55.77 Mn
Dec 31, 2018 4.21 Mn
Dec 31, 2018 4.21 Mn
Jun 30, 2018 -22.71 Mn
Jun 30, 2018 -22.71 Mn
Mar 31, 2018 8.02 Mn
Mar 31, 2018 8.02 Mn
Dec 31, 2017 48.35 Mn
Dec 31, 2017 48.35 Mn
Jun 30, 2017 34.54 Mn
Jun 30, 2017 34.54 Mn
Mar 31, 2017 19.09 Mn
Mar 31, 2017 19.09 Mn
Dec 31, 2016 81.49 Mn
Dec 31, 2016 81.49 Mn